Skip to main navigation Skip to search Skip to main content

Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India

  • Shashidhar V. Karpurmath*
  • , Arun Seshachalam
  • , Kalaiselvi Selvaraj
  • , Priyadarshini Rajamani
  • , Satish kumar
  • , Neelesh Reddy
  • , Baswant Malipatil
  • , Roopa Sirigeri
  • , Krishna Prasad
  • , Krishna Reddy
  • , Madhav Danthala
  • , Karthik S. Udupa
  • , Manjunath Nandennavar
  • , Janarthinakani Murugesan
  • , C. N. Patil
  • , Parameswaran Anoop
  • , Roshan Koshy Jacob
  • , Mallikarjun Kalashetty
  • , Krishnakumar Rathnam
  • , Ramanan Ganapathy
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India'. Together they form a unique fingerprint.
Sort by

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science